In vitro & in vivo taste masking
Introduction
Ciprofloxacin (CP) has been used for the several diseases such as infection of bones and joints, gastroenteritis and also approved for the treatment of infections, especially urinary tract infections, prostatitis [1] . It is a second-generation flouroquinolone antibiotic drug having excellent tissue penetration used for both oral and intravenous formulations [2, 3] . Although CP has good broad spectrum antibacterial activity, it has bitter taste which becomes palatability challenge and has patients compliance for oral administration.
Oral administration of drug is considered to be the most preferred route for drug delivery. Taste of an oral formulation administered, particularly of bitter drugs, to a child or adult has an important impact on the adherence to drug therapy. Taste masking is an important challenge in drug delivery since drugs dissociate in the patients mouth in close proximity to the taste buds, thereby increasing the patients compliance. A variety of methods are available for taste masking purpose such as microencapsulation with various polymers, coating with polymers lipids, drug resin complexes and using lipophilic vehicles for obstructing the taste buds [4e6] . These methods are used to prevent instant drug release, when contact with the taste bud in the oral cavity [7e9] . Among various taste masking techniques, complexation method using ion exchange resins (IERs) is simple, cost effective and does not require more ingredients or organic solvents.
IERs have excellent properties like high ion-exchange capacity, good absorption capacity, physico-chemical stability and their insolubility in any solvents make them suitable candidates as taste masking and sustain release of drugs [10e12] . CP has been studied for taste masking and sustain release by some researchers. Pisal et al. studied taste masking of CP using Indion 234 resin and also studied for sustain release of CP at SGF pH by treating polyethylene glycol with CP-Indion 234 complex [13, 14] . Extended release tablet was prepared by using 500 mg of CP on swellable drug polyelectrolyte matrices by Bermudez et al. [15] .
Interpenetrating polymer network (IPN) beads have been used by many researchers for sustain release of drugs in recent years. IPN beads proved to be a novel drug carrier as they have many good properties [16] . They are stable, biocompatible, non-toxic and biodegradable which have attracted their use in pharmaceutical field. Chitosan (CS) is environment friendly bio material, non-toxic, biodegradable, biocompatible, hydrophilic and semi-rigid polysaccharide which has been studied for the controlled release of drugs in the present work. CS is derived from naturally occurring chitin by alkaline deacetylation. CS also possesses good mucoadhesive property and several researchers have used CS for the entrapment of drugs [17e20]. Sodium alginate (AL) is a polysaccharide and composed of b-D mannuronic acid and a-D-guluronic acid polymer which can vary in proportion and sequential distribution [21] . However, the taste masking and sustain release of CP through synthesized IERs based IPN beads using CS and AL biopolymers are relatively new area which prompted us to study them in details.
The objective of this study was to evaluate the performance of the synthesised resins for taste masking of CP followed by sustain release at different pH by forming IPN beads with AL and CS biopolymers. The IERs were prepared with different cross linkers and also by varying crosslinking %. These IERs have high ion exchange capacity (>11 meq/gm), stability and insolubility properties as well as possess high drug loading capacity.
2.
Materials and methods 
Synthesis of IERs
IERs were synthesized by following suspension polymerization technique with some modifications as reported in our earlier work in the presence of n-heptane and isobutanol as diluents [22] . Series of AA based IERs were prepared by varying quantities of EGDMA, MBA and DVB. They are coded as AEC-1, AEC-2, AEC-3, AEC-4, ABC-1, ABC-2, ABC-3 ABC-4, ADC-1, ADC-2 and ADC-3 respectively. The details of the synthesis of IERs are given in Table 1 . IERs were conditioned by giving alternate treatment of acid (1 N HCl) and base (1 N NaOH) with intermittent water (Millipore water) rinsing for three cycles and finally converted to K þ form with KOH for further study.
Preparation of drug resin complexes (DRCs)
DRCs were prepared from IERs and drug by following batch method [23] . CP was dissolved in Millipore water and swelled IERs were slowly added under constant stirring with a magnetic stirrer (Remi model no: FHMS-3762, Mumbai, India). Each mixture was stirred at a speed of 500 rpm at room temperature for 24 h. The resultant DRCs were separated by centrifugation. The supernatant solution was filtered and set for HPLC analysis at 275 nm in order to find out loading of CP on IERs.
IERs showing comparatively higher up take of drug (i.e. >80%) was chosen from each series to prepare DRCs by varying the ratios of AEC-1, ABC-2 and ADC-3 with CP i.e. 1:1, 1:2 and1:4 (w/w) to study their taste masking property in details. 
In vitro and in vivo taste masking studies
In vitro taste masking study of CP and DRCs prepared with AEC-1, ABC-2 and ADC-3 in different ratios i.e. 1:1, 1:2 and1:4 (w/w) was carried out at simulated salivary fluid (SSF) pH 6.8. Pre-decided amount of DRCs was dispersed in 5 ml SSF in conical flasks separately [24] . Samples of 1 ml were withdrawn from the conical flask at time intervals of 30 s and filtered with 0.45 mm Whatman filter paper. The filtrates were analysed for CP at 275 nm by using HPLC. This study was performed in triplicate for each sample, and the average values for respective DRCs were reported.
In vivo taste masking study of CP, DRCs prepared with AEC-1, ABC-2 and ADC-3 and PMs prepared with ADC-3 was performed by a panel of 9 Human volunteers in the age group of 18e30 years of both the sexes from whom written consent was obtained after getting approval from Human Ethic Committee (HEC no. 423/2014) of the Government Medical College, Bhavnagar, Gujarat. CP, different ratios DRCs prepared by CP with AEC-1, ABC-2 and ADC-3 IERs i.e. 1:1, 1:2 and1:4 (w/w) and PMs prepared with ADC-3 IER at ratio 1:1, 1:2 and 1:4 were placed on tongue by each volunteer separately and taste was evaluated for 30 s resident time by reported method [25] . Volunteers were asked to gargle immediately after each evaluation. The bitterness was recorded immediately according to the bitterness scale ranging from 0 to 5 (0-No Bitter, 1-Threshold Bitter, 2-Slight Bitter, 3-Moderate Bitter, 4-Bitter and 5-Strong Bitter). The bitterness of DRCs experienced by the volunteers was reported.
Powder X-ray diffraction (P-XRD)
ADC-3, CP, ADC 1:4 and PM 1:4 were investigated by Powder Xray diffraction (P-XRD, Phillips-X 0 Pert MPD System) Netherland. P-XRD was recorded from 2 to 60 (2q) at a scanning speed of 0.3 deg/s. PW3123/00 curved Ni-filtered Cu-Ka (l ¼ 1.54056 Å) radiation was used as the X-ray source.
Fourier transforms infrared spectroscopy (FT-IR)
FT-IR was recorded on PerkineElmer, GX-FTIR, GX series 49387 (Spectrum GX, USA). The samples were mixed with KBr and converted into pellets at 100 Kg pressure using a hydraulic press. The spectra were obtained at the wavelength range 4000e400 cm
À1
.
Scanning electron microscopy (SEM)
SEM images of dried ADC-3, CP, ADC 1:4 and PM 1:4 were recorded by using LEO Instruments (Kowloon, Hong Kong) microscope after the gold sputter coating on desired samples. The samples were prepared in Millipore water and dried on aluminium grids at room temperature prior to SEM analysis. 
Differential scanning calorimetry (DSC)
ADC
Preparation of ADC 1:4-AL and ADC 1:4-AL-CS IPN beads
A known amount of ADC 1:4 containing 20 mg of CP was mixed with 20 ml of 2% AL aqueous solution and stirred for 2 h to get homogenous suspension. The solution was filled in 25 ml syringe having needle size 1.2 mm and poured at a distance of 15 cm height in 0.25 M CaCl 2 solution under mild stirring at room temperature. The beads formed by ionic gelation were cured for 30 min at room temperature followed by washing with Millipore water and finally dried at room temperature until constant weight was obtained.
For the synthesis ADC 1:4-AL-CS IPN beads, ADC 1:4 containing 20 mg of CP was mixed with 20 ml of 2% AL solution. The mixture was stirred for 2 h to get homogenous suspension solution. CS solution containing 2% was prepared separately in acidic media at pH 4.5 under constant stirring at room temperature and mixed in 0.25 M CaCl 2 solution. The ADC 1:4 containing AL solution was dropped by using 25 ml syringe of needle size 1.2 mm at a distance of 15 cm height with mild stirring in the mixture containing of CS and CaCl 2 solution. The beads were cured for 30 min at room temperature followed by washing with distilled water and finally dried at a s i a n j o u r n a l o f p h a r m a c e u t i c a l s c i e n c e s 1 0 ( 2 0 1 5 ) 3 3 1 e3 4 0 room temperature till the constant weight was obtained. Fig. 1 shows the schematic diagram for the preparation of ADC 1:4-AL and ADC 1:4-AL-CS IPN beads by ionic crosslinking method. Mean diameter of dry beads was measured with micrometer screw (Mitutoyo, Japan) and entrapment efficiency (%) of CP in ADC 1:4-AL and in ADC 1:4-AL-CS was determined by HPLC at 275 nm by measuring the left CP in CaCl 2 solution during the preparation of IPN beads. The entrapment efficiency was calculated by using following eqn.
where C1 is the known concentration of CP in ADC 1:4 and C2 is the concentration of CP in CaCl 2 solution.
High pressure liquid chromatography (HPLC)
The quantitative analysis of drug (CP) was performed using HPLC system of Waters Alliance model with Waters 2996 Photo Diode array Detector. The stationary phase was Enable C18H (Shimadzu). The mobile phase was a mixture 0.25 M H 3 PO 4 and acetonitrile in the ratios of 60:40. UV detector was set at 275 nm and oven temperature was maintained at 30 C.
The flow rate of mobile phase was 1.0 ml/min and the injection volume was 20 ml/ml. The sample temperature was maintained at 10 C.
In vitro release studies
Buffer solution of pH 1. [26] . The dialysis bags were dipped into receptor compartment containing 100 ml of medium and was shaken at 37 ± 0.5 C at a shaking speed of 100 rpm on Remi shaking water bath (Model no: RSB-12, Mumbai, India), whereas ADC 1:4-AL and ADC 1:4-AL-CS were studied by incubating 10 mg of CP containing IPN beads in 100 ml of SGF (pH 1.2) in 125 ml conical flask kept in a shaking water bath at 37 ± 0.5 C at a shaking speed of 100 rpm/min. After 3 h, the beads were filtered and transferred to 100 ml of SIF (pH 7.4) and incubated at 37 ± 0.5 C at a shaking speed of 100 rpm/min. At desired intervals of time, 1 ml sample was withdrawn and replaced with same amount of fresh medium and analysed by HPLC. Receptor compartment was closed to prevent the evaporation losses from the medium. The study was performed for three times.
Drug release kinetics
The drug release kinetics was performed for ADC 1:4-AL and ADC 1:4-AL-CS IPN beads. The results obtained were fitted into two kinetics models; Higuchi and Korsmeyer-Peppas. Higuchi model describes the release of drugs as a square root of time based on Fickian diffusion.
k H is a constant reflecting the design variables of the system. The release of drug from complexes was fitted by Korsmeyer-Peppas model to find out the mechanism of drug release by following equation [27] .
where M t /M ∞ is the fraction of drug released at time t, K is rate constant and n is the diffusion exponent characteristic of release mechanism. The n value indicates the type of release mechanism. The values of n between 0.45 and 0.85 are due to the diffusion controlled and swelling controlled transport mechanism (anomalous/non-Fickian transport), the values above 0.85 indicate case II transport mechanism (zero order) which indicates polymer relaxation takes place during polymer swelling.
Statistical analysis
All data are presented as mean ± standard deviation. Statistical significance was assessed by using IBM SPSS statistics version 21 software by two-way ANOVA with Duncan's multiple range test. A probability level of p < 0.05 was considered to be statistically significant.
Results and discussion

Drug loading on synthesized IERs
Fig . 2 shows the percentage of drug loading on all IERs. The loading of CP was carried out to select the IERs from each series with highest drug loading capacity and to study them in detail for taste masking. The drug loading on IERs was found 
to be in the range of 72 %e92 %. IERs with low degree of crosslinking showed high loading of CP whereas the drug loading is low for the IERs of high degree of crosslinking. This trend is due to decrease in the availability of functional groups on the IERs matrix at higher degree of crosslinking. The loading of CP may be due to breaking of the van der Waals forces between the drug molecules of carboxylic groups and ion exchange reaction also takes place during the complex formation between IERs and drug.
Effect of drug loading on different ratios of IERs
The loading of CP on AEC-1, ABC-2 and ADC-3 at 1:1, 1:2 and 1:4 ratios are tabulated in Table 2 . Loading of CP increases with the increase in the quantity of IERs and ADC-3 at 1:2 ratio showed higher loading of CP compared to other IERs.
In vivo and in vitro taste masking at SSF pH
Taste masking efficiency of CP, DRCs prepared with AEC-1, ABC-2 and ADC-3 and PMs prepared with ADC-3 were carried out by in vivo and the results are shown in Fig. 3A . The statistical analysis showed significant suppression (P < 0.05) for the drug. The taste masking of CP by different IERs was observed in the following order AEC-1>ABC-2>ADC-3. Taste evaluation by volunteers graded ADC 1:4 of ADC-3 (value 0.66 Fig. 3A) as tasteless as compared to other DRCs. The taste masking value is found to be below 2 which signify the good taste masking of DRCs and this has been explained by Maniruzzaman et al. [25] .
In vitro taste masking efficiency of the DRCs prepared with AEC-1, ABC-2 and ADC3 was studied for the release of CP at SSF pH and the results are shown in Fig. 3B . The release of CP from DRCs was in the following order AEC-1>ABC-2>ADC-3. ADC 1:4 showed only 4.26 ± 0.38% of CP release for a contact time of 30 s ultimately resulting in better taste masking. The probable reason is that at pH 6.8, counter ions available to exchange amine groups present in CP of ADC-3 complex are not sufficient due the presence of crosslinked bulky and hydrophobic DVB group which ultimately results in slow release of CP. Whereas faster drug release in case of AEC-1 and ABC-2 is observed as the copolymers possess aliphatic cross-linkers such as EGDMA and MBA which may allow fast release of drug as compared to ADC-3. 
3.2.
Instrumental analysis and in-vitro drug release studies 
formation of complex. This finding confirms that the entrapped CP is dispersed monomolecularly on ADC-3 matrix [29] . PM 1:4 retained the peaks of CP due to its crystal nature and some diffused peaks due to ADC-3 which indicate that there is no complex formation. Table 3 of ADC 1:4-AL was found to be 533 ± 12 mm whereas it was increased up to 932 ± 26 mm for ADC 1:4-AL-CS; this may be due to formation of ionic crosslinking between AL of eCOOH and CS of NH 3 þ with Ca 2þ which ultimately resulted in the increases of bead size. The increases in bead sizes have also reported by previous researchers [30, 31] . Fig. 6A shows the mechanism of ionic crosslinking with Ca 2þ between two polymer strands of AL and ionic interaction between CS of NH 3 þ and COOH of AL during the formation of IPN beads [30] . The mechanism was confirmed by the FTIR spectra. Table 3 and found to be 91.85 ± 1.22% and 90.28 ± 0.85% respectively which indicate that ADC 1:4 has been well entrapped by the biopolymers matrices. The high entrapment value indicates that during gelation ionic crosslinking takes place between eCOOH group of AL and NH 3 þ group of CS. The other reason may be the low pH of the solution causes ionic crosslinking between CS and AL [31] .
Drug release profile
The drug release profile of ADC 1:4, ADC 1:4-AL and ADC 1:4-AL-CS at gastric pH i.e. 1.2 is presented in Fig. 7 . The release of CP was completed within 60 min for ADC 1:4 and was found to be 92.53 ± 1.98%. In case of IPN beads of ADC 1:4-AL and ADC 1:4-AL-CS the release of CP was studied for the initial period of 3 h at SGF pH. The rate of drug release was slow (<20%) for the IPN beads and it follows the following order i.e. 
diagram of IPN beads at pH 1.2. Fig. 8B shows the photographs of IPN beads at pH 1.2 after 3 h Fig. 8C shows the complete degradation of ionic crosslinking at SIF pH. Fig. 8D shows the photograph of degraded IPN beads at pH 7.4 after 10 h.
Kinetics studies by Higuchi and Korsmeyer Peppas model
The kinetics studies of ADC 1:4-AL and ADC 1:4-AL-CS were carried out by using two models Higuchi and Korsmeyer
Peppas model. The values of correlation coefficient (r 2 ) and rate constants (k) are tabulated in Table 4 . The diffusion exponent ''n'' of ADC 1:4-AL and ADC 1:4-AL-CS follows anomalous (non-fickian) diffusion in all medium. The n value increased from the ADC 1:4-AL to ADC 1:4-AL-CS IPN beads show the crosslinking effect between the AL and CS. This indicates that mechanism depends on both diffusion and swelling control. The r 2 was near to unity and shows the best fit to non fickian model [32] .
Conclusion
IERs with highest drug loading were studied for the taste masking of CP. In vitro and in vivo taste masking studies showed ADC 1:4 have good taste masking properties compared to other DRCs. FT-IR spectra confirmed the possible interaction between the drug and IERs. P-XRD and DSC confirmed that drug was in amorphous state in the IERs by forming complexes. ADC 1:4 studied for sustain release by 
forming IPN beads with AL and CS. The CP release was very slow in SGF media and when transferred into SIF media the release of CP was due to the degradation of ionic crosslinking of IPN beads. The kinetic study of model showed the release of CP depends on non Fickian diffusion.
